Dianthus Therapeutics, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $17.7M | $161.6M | $58.2M |
| FY2021 | $17.3M | $189.9M | $131.7M |
| FY2022 | $9.5M | $83.1M | $15.4M |
| FY2023 | $10.5M | $179.4M | $132.3M |
| FY2024 | $21.5M | $374.0M | $22.8M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2020 | $17.7M | $161.6M | $58.2M |
| FY2021 | $17.3M | $189.9M | $131.7M |
| FY2022 | $9.5M | $83.1M | $15.4M |
| FY2023 | $10.5M | $179.4M | $132.3M |
| FY2024 | $21.5M | $374.0M | $22.8M |